Materiality and stakeholders

(DMA, G4-17, G4-18, G4-19, G4-20, G4-21, G4-22, G4-23, G4-24, G4-25, G4-26, G4-27)

The analysis of materiality or relevant aspects in sustainability of Genomma Lab Internacional covers the entities included in our financial statements and that, as a whole, make up to Genomma Lab Internacional S.A.B. Of C.V. and subsidiaries.

Genomma Lab Internacional S.A.B. de C.V. and subsidiaries

  • Genomma Laboratories México, S.A. de C.V.
  • Television Products Retail, S.A. de C.V.
  • Medicinas y Medicamentos Nacionales, S.A. de C.V.
  • Iniciativas de Éxito, S.A. de C.V.
  • Aero Lab, S.A. de C.V.
  • Servicios Logísticos Genomma, S.A. de C.V.
  • Genomma Lab USA, Inc.
  • Genomma Lab Centroamérica, S. A.
  • Genomma Lab Perú, S.A.
  • Genomma Lab Chile, S.A.
  • Genomma Lab Ecuador, S.A.
  • Genomma Laboratories Argentina, S.A.
  • Genomma Lab Colombia, LTDA
  • Genomma Laboratories do Brasil, LTDA
  • Genomma Lab Dominicana, S.R.L.
  • The Dutch-LATEM Royalty Company, B. V

Genomma Lab Internacional’s Corporate Social Responsibility strategy integrates the relevant aspects identified in the analysis of materiality and the corporate imperatives derived from our business strategy. The points that our main stakeholders consider important, as well as the priorities for each of the national and international entities of Genomma Lab Internacional, are considered in the information disclosed in this report.

The methodology of the analysis of materiality consists of the identification, prioritization, review and validation of the issues that our company and stakeholders consider relevant. To carry out this evaluation, information was obtained from various sources, among which the following stand out:

The assessment is based on international standards, supporting our analysis on comparable and robust information. As a result, we obtained a materiality matrix that classifies the information into two main areas: risk and maturity:


Refers to the level of impacts that have not yet materialized, but if they do so, may eventually affect our stakeholders. Issues that fall into this category should be included in action plans in order to mitigate them.


Should be understood as the level of attention that our stakeholders pay to certain sustainability aspects. It includes those issues that are addressed from within the organization and are externally communicated by public media.

The two previous criteria allow us to classify the aspects of sustainability as emerging, generalized, urgent and necessary, thus determining the approach with which we must address them. Calculations, weights and scores are performed to obtain reliable, repeatable and consistent results, which serve as a basis for prioritizing future strategic actions, investments and communications; in the same way, we rely on these to define the scope and coverage of the content of our Sustainability Reports.

Within the materiality analysis of Genomma Lab Internacional, several companies from the pharmaceutical and personal care sector were considered, identifying the degree of maturity of those companies for those aspects of sustainability that are publicly disclosed. We identified the following topics as those of greater disclosure:

  • Management of sustainable development.
  • Policy and environmental management system.
  • Relationship with government and public policy.
  • Waste management.

We also identify topics that represent a greater risk for Genomma Lab Internacional, which are:

  • Management of sustainable development.
  • Relationship with government and public policy.
  • Financial topics.
  • Operations.
  • Access to health.
  • Management of water resources.
  • Talent attraction and retention.
  • Ethics and Integrity.
  • Corporate Governance.
  • Corruption, bribery and transparency.

Of the topics that were classified as generalized (environmental affairs, employee satisfaction and human rights), we compared our performance against that of the companies that are considered leaders in the sector. As a result of the above, we established strategies and action plans to continue improving our performance in these matters, thus generating more value to our stakeholders.


Reporte de Sustentabilidad 2016 de Genomma Lab Internacional